跳至主要内容
临床试验/ACTRN12616001162404
ACTRN12616001162404终止未知

Comparing clinical symptoms and features of the microbiome and metabolome in diarrhoea predominant and mixed irritable bowel syndrome (IBS) patients with and without small intestine bacterial overgrowth (SIBO).

Dunedin School of Medicine, University of Otago0 个研究点目标入组 220 人开始时间: 2016年8月26日最近更新:

试验速览

阶段
未知
状态
终止
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Participants with IBS (D) or IBS (M) according to Rome III criteria who are fluent in English. Healthy controls are female and male, aged 18-65 with no gastrointestinal physiology and fluent in English.

排除标准

  • Organic gastrointestinal disease (e.g. coeliac, IBD),
  • Serious neurological or respiratory conditions
  • Previous gastrointestinal surgery (except appendectomy),
  • Pancreatitis,
  • Previous radiotherapy to the abdominal area or chemotherapy,
  • Pregnancy and lactation,
  • Antibiotics or probiotics within the last 6 weeks,

研究者

发起方
Dunedin School of Medicine, University of Otago

相似试验